Dr Francesco Rainone

Dr Francesco Rainone

Contact details:



MB ChB:  University of Vita-Salute San Raffaele Milan, Italy, 2007

CCT (Renal med):  University of Vita-Salute San Raffaele Milan, Italy 2013

Present appointments:

  • Consultant Renal Physician, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust: April 2014 – present
  • Honorary Lecturer in Cardiovascular Sciences, School of Medical Sciences, University of Manchester: January 2019 – present
  • Divisional Mortality Lead (Tertiary Medicine): January 2017 – present
  • Patient Safety Committee Member (UKKA): June 2019 – present

Previous appointments:

  • Locum Consultant Renal Physician, Ospedale San Raffaele, Milan (Italy): 01/04/2013 – 31/07/2014)
  • Locum Consultant Renal Physician, Ospedale Civile, Sondrio (Italy): 01/08/2013 – 09/03/2014
  • Locum Consultant Renal Physician, Salford Royal NHS Foundation Trust: 04/04/2014 – 09/08/2015

Research interests/expertise:

  • Dysproteinaemic renal diseases
  • Monoclonal gammopathy of renal significance (MGRS)
  • Glomerulonephritis

Current research grants:

  • PROTECT-V Trial, Principal Investigator, Cambridge University Hospitals NHS Foundation Trust, (August 2021 – ongoing)

Publications (last 5 years):


McDonnell T, Storrar J, Chinnadurai R, Heal C, Chrysochou C, Ritchie J, Rainone F, Poulikakos D, Kalra P, Sinha S, The epidemiology of primary FSGS including cluster analysis over a 20-year period. BMC Nephrol. 2023 Dec 10;24(1):365.


Storrar J, Gill-Taylor T, Chinnadurai R, Chrysochou C, Poulikakos D, Rainone F, Ritchie J, Lamerton E, Kalra PA, Sinha S. A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades. PLoS One 2022 Oct 13;17(10):e0276053.


Lodge MDS, Abeygunaratne T, Alderson H, Ali I, Brown N, Chrysochou C, Donne R, Erekosima I, Evans P, Flanagan E, Gray S, Green D, Hegarty J, Hyde A, Kalra PA, Lamerton E, Lewis D, Middleton R, New D, Nipah R, O’Donoghue D, O’Riordan E, Poulikakos D, Rainone F, Raman M, Ritchie J, Sinha S, Wood G, Tollitt J. Safely reducing haemodialysis frequency during the COVID-19 pandemic. BMC Nephrol. 2020 Dec 7;21(1):532.



Skip to content